Rapid detection of a cancer biomarker by a microfluidic chip

1 Apr 2021 | Publications, Research

Researchers from LAAS-CNRS, in collaboration with the Toulouse Cancer Research Centre, have shown how μLAS microfluidic chip technology can concentrate and measure microRNAs, cancer biomarkers, in less than a minute. MicroRNAs (miRs) are short fragments of RNA that...

The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body.

23 Mar 2021 | Publications, Research

PI3Ks are important molecules, that, by adding a tag on a lipid, induce messages (also called signals) in the cells. They are hence key regulators of cell signalling. In the animals of higher order, such as Humans, PI3Ks come in different flavours. In particular, the...

Congratulation to Benoît Thibault, Axis 1 poster prize during the 16th Cancéropôle GSO Days

25 Nov 2020 | Research

An unmissable event for researchers and clinicians from the Greater South-West, the Annual Days are a place for exchange, providing an opportunity to take stock of the Cancéropôle’s programmes and strategic areas of focus. These meetings encourage closer links...

Treatment of testicular cancers with high doses of etoposide: impact of the elimination capacities of the drug and the genetic characteristics of the patient on the efficacy and toxicity of the treatment

31 Jul 2020 | Publications, Research

For patients with refractory or relapsing testicular cancer after standard chemotherapy, more aggressive chemotherapy with carboplatin and etoposide may be used. After this high-dose chemotherapy, a stem cell transplant is performed to replace those that have been...

A patient gene expression similarity approach leads to new perspectives in disease comorbidity

25 Jun 2020 | Publications, Research

The fact that many people suffer from more than one disease, known as comorbidity, has become one of the main challenges for the 21st century aging population, as it mainly affects the elderly, decreasing treatment options and patients’ life expectancy while...

A small non-coding RNA molecule controls the presence of three key tumor growth regulators of NPM-ALK(+) T lymphoma.

15 May 2020 | Publications, Research

Lymphoma is a blood cancer which develops from a type of white blood cells present in the lymphatic system; the lymphocytes. There are two types of lymphocytes: B lymphocytes and T lymphocytes. This study focuses on a particular type of blood cancer affecting T...